Congenital Anomalies in Children of Patients Who Received Chemotherapy for Cancer in Childhood and Adolescence
Open Access
- 18 July 1991
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 325 (3) , 141-146
- https://doi.org/10.1056/nejm199107183250301
Abstract
Many patients who have been treated successfully for childhood cancer with regimens that contain one or more mutagenic chemotherapeutic agents are concerned that their own treatment during childhood or adolescence may adversely affect their children.Keywords
This publication has 22 references indexed in Scilit:
- Pregnancy outcome after treatment for acute lymphoblastic leukemia during childhood or adolescenceCancer, 1989
- Increased somatic cell mutant frequency in atomic bomb survivorsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1988
- Reproductive problems and birth defects in survivors of Wilms' tumor and their relativesMedical and Pediatric Oncology, 1988
- Evidence for Increased Somatic Cell Mutations at the Glycophorin A Locus in Atomic Bomb SurvivorsScience, 1987
- Incidence of cardiac septal defects in children with Wilms' tumour and other malignant diseasesCarcinogenesis: Integrative Cancer Research, 1987
- Somatic gene mutations in vivo as indicated by the 6-thioguanine-resistant T-lymphocytes in human bloodMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1985
- Genotoxic classification of anticancer drugsTeratogenesis, Carcinogenesis, and Mutagenesis, 1985
- Structure-Activity Relationships in the Carcinogenicity of Anticancer AgentsDrug Metabolism Reviews, 1984
- Comparison of the Relative Mutagenic Activity for Eight Antineoplastic Drugs in the Ames Salmonella/Microsome and TK+/− Mouse Lymphoma AssaysDrug and Chemical Toxicology, 1978
- PROGENY OF CHILDHOOD-CANCER SURVIVORSThe Lancet, 1974